Cutting edge:: Expression of chemokine receptor CXCR1 on human effector CD8+ T cells

被引:65
作者
Takata, H [1 ]
Tomiyama, H [1 ]
Fujiwara, M [1 ]
Kobayashi, N [1 ]
Takiguchi, M [1 ]
机构
[1] Kumamoto Univ, Ctr AIDS Res, Div Viral Immunol, Kumamoto 8600811, Japan
关键词
D O I
10.4049/jimmunol.173.4.2231
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
IL-8 is a potent inflammatory cytokine that induces chemotaxis of neutrophils expressing CXCR1 and CXCR2, thus indicating its involvement in the migration of these cells to inflammatory sites where bacteria proliferate. Presently, we showed that CXCR1(+) cells were predominantly found among CD8(+) T cells having effector phenotype, and that the expression of CXCR1 was positively correlated with that of perform, suggesting that CXCR1 is expressed on effector CD8(+) T cells. Indeed, human CMV-specific CD8(+) T cells from healthy individuals, which mostly express the effector phenotype and have cytolytic function, expressed CXCR1, whereas EBV-specific CD8(+) T cells, which mostly express the memory phenotype and have no cytolytic function, did not express this receptor. The results of a chemotaxis assay showed that the migration of CXCR1(+)CD8(+) T cells was induced by IL-8. These results suggest that the IL-8-CXCR1 pathway plays an important role in the homing of effector CD8(+) T cells.
引用
收藏
页码:2231 / 2235
页数:5
相关论文
共 20 条
[1]   The CXC chemokines growth-regulated oncogene (GRO) alpha, GRO beta, GRO gamma, neutrophil-activating peptide-2, and epithelial cell-derived neutrophil-activating peptide-78 are potent agonists for the type B, but not the type A, human interleukin-8 receptor [J].
Ahuja, SK ;
Murphy, PM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (34) :20545-20550
[2]   Phenotypic analysis of antigen-specific T lymphocytes [J].
Altman, JD ;
Moss, PAH ;
Goulder, PJR ;
Barouch, DH ;
McHeyzerWilliams, MG ;
Bell, JI ;
McMichael, AJ ;
Davis, MM .
SCIENCE, 1996, 274 (5284) :94-96
[3]  
CHUNTHARAPAI A, 1994, J IMMUNOL, V153, P5682
[4]   Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues [J].
Goodarzi, K ;
Goodarzi, M ;
Tager, AM ;
Luster, AD ;
von Andrian, UH .
NATURE IMMUNOLOGY, 2003, 4 (10) :965-973
[5]   To kill or to cure: Options in host defense against viral infection [J].
Guidotti, LG ;
Chisari, FV .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (04) :478-483
[6]   Phenotypic and functional separation of memory and effector human CD8(+) T cells [J].
Hamann, D ;
Baars, P ;
Rep, MHG ;
Hooibrink, B ;
KerkhofGarde, SR ;
Klein, MR ;
vanLier, RAW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (09) :1407-1418
[7]   Expression and regulation of chemokine receptors in human natural killer cells [J].
Inngjerdingen, M ;
Damaj, B ;
Maghazachi, AA .
BLOOD, 2001, 97 (02) :367-375
[8]   Molecular and functional profiling of memory CD8 T cell differentiation [J].
Kaech, SM ;
Hemby, S ;
Kersh, E ;
Ahmed, R .
CELL, 2002, 111 (06) :837-851
[9]   Controlling HIV pathogenesis: The role of the noncytotoxic anti-HIV response of CD8(+) T cells [J].
Levy, JA ;
Mackewicz, CE ;
Barker, E .
IMMUNOLOGY TODAY, 1996, 17 (05) :217-224
[10]   Mast cell-dependent migration of effector CD8+ T cells through production of leukotriene B4 [J].
Ott, VL ;
Cambier, JC ;
Kappler, J ;
Marrack, P ;
Swanson, BJ .
NATURE IMMUNOLOGY, 2003, 4 (10) :974-981